Wednesday, April 17, 2024 10:06:20 AM
Looks to me like the above approach is now being used prevalently and accounts for much of the growth in share count. Consequently, the next Quarterly Report will show an increase in revenue from product sales; when in truth it is dilution disguised as product sales. The shares were sold and the product was given away.
At today's PPS, $70,000 in share sales (1,000,000 shares) can be disguised as $70,000 in product sales. One can do a lot of "creative" financing & accounting gimmicks when your #s don't have to be audited.
"Libenter homines id quod volunt credunt"
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM